Autonomix Medical Files Definitive Proxy Statement

TL;DR

Autonomix Medical filed its proxy statement, shareholders vote soon.

AI Summary

Autonomix Medical, Inc. filed a definitive proxy statement (DEF 14A) on September 4, 2024, for its annual meeting of stockholders. The filing indicates no fee was required for this filing, and it pertains to the company's fiscal year ending March 31, 2024. The company is based in The Woodlands, Texas.

Why It Matters

This filing is crucial for shareholders as it outlines the agenda and proposals for the company's annual meeting, allowing them to make informed voting decisions.

Risk Assessment

Risk Level: low — This is a routine regulatory filing for an annual meeting and does not contain new financial or operational disclosures that would immediately impact risk.

Key Numbers

• 0331 — Fiscal Year End (Indicates the end of the company's financial reporting year.)

Key Players & Entities

• Autonomix Medical, Inc. (company) — Registrant
• 0001437749-24-028431 (filing_id) — Accession Number
• 20240904 (date) — Filing Date
• 20241017 (date) — Period of Report
• The Woodlands, TX (location) — Company Address

FAQ

Filing Documents

• amix20240903_def14a.htm (DEF 14A) — 467KB
• a01.jpg (GRAPHIC) — 211KB
• 0001437749-24-028431.txt ( ) — 758KB

From the Filing

DEF 14A 1 amix20240903_def14a.htm FORM DEF 14A amix20240903_def14a.htm Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 Autonomix Medical, Inc. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 Table of Contents Autonomix Medical, Inc. 21 Waterway Avenue, Suite 300 The Woodlands, TX 77380 (713) 588-6150 To the Stockholders of Autonomix Medical, Inc.: On behalf of the Board of Directors (the "Board") and management of Autonomix Medical, Inc. (the "Company"), you are cordially invited to attend the Annual Meeting of Stockholders of the Company on October 17, 2024 (the "Annual Meeting"). The Annual Meeting will be held at the principal executive offices of the Company, 21 Waterway Avenue, Suite 300, The Woodlands, TX 77380 and begin at 10:00 a.m. Central Time. In accordance with the Securities and Exchange Commission's "notice and access" model, we are providing our Notice of Annual Meeting of Shareholders, Proxy Statement and Annual Report on Form 10-K for the year ended March 31, 2024 to you online with paper copies available, free of charge, upon request. On or about September 4, 2024, we will begin mailing a Notice of Internet Availability of Proxy Materials detailing how to access the proxy materials electronically and how to submit your proxy via the Internet. The Notice of Internet Availability of Proxy Materials also provides instructions on how to request and obtain paper copies of the proxy materials and proxy card or voting instruction form, as applicable. The Notice of Internet Availability of Proxy Materials is not a proxy card and cannot be used to vote your shares. We believe this process provides our shareholders with a convenient way to access the proxy materials and submit their proxies online, while allowing us to reduce our environmental impact as well as the costs of printing and distribution. Shareholders of record at the close of business on August 26, 2024 are entitled to vote on the matters presented at the Annual Meeting. We intend to hold our Annual Meeting in person and we look forward to seeing you on October 17, 2024. We encourage you to attend the Annual Meeting, but if you are unable to attend, it is important that you vote in advance via the Internet, or by signing, dating and returning the proxy card. Your cooperation is appreciated since a majority of the common stock must be represented, either in person or by proxy, to constitute a quorum for the transaction of business at the Annual Meeting. Very truly yours, Autonomix Medical, Inc. By: /s/ Walter V. Klemp Walter V. Klemp Executive Chairman of the Board Important Notice Regarding the Availability of Proxy Materials for the Annual Shareholder Meeting to be Held on October 17, 2024: Electronic Copies of the Proxy Statement and our 2024 Annual Report on Form 10-K are available at https://www.AMIX.vote Table of Contents Autonomix Medical, Inc. 21 Waterway Avenue, Suite 300 The Woodlands, TX 77380 (713) 588-6150 NOTICE OF ANNUAL MEETING OF STOCKHOLDERS To Be Held October 17, 2024 TO THE STOCKHOLDERS OF AUTONOMIX MEDICAL, INC.: NOTICE IS HEREBY GIVEN that the 2024 Annual Meeting of Stockholders of Autonomix Medical, Inc. (the "Company") will be held at the principal executive offices of the Company, 21 Waterway Avenue, Suite 300, The Woodlands, TX 77380 and begin at 10:00 a.m. Central Time, for the following purposes, as described in the accompanying Proxy Statement: 1. To elect five Board nominees to the Board of Directors of the Company, each to serve until the 2025 annual meeting of stockholders of the Company or until such person's successor is qualified and elected. 2. To ratify the appointment of Forvis Mazars, LLP as the Company's independent registered public accounting firm for the year ending March 31, 2025. 3. To approve an amendment to the Company's amended and restated certificate of incorporation to grant our Board of Directors authority to effect a reverse stock split of the outstanding shares of the Company's common stock, at a reverse stock split ratio of between 1-for-2 to 1-for-50 (or any whole number in between), as determined by the Board in its sole discretion, prior to the one-year anniversary of

View Full Filing

View this DEF 14A filing on SEC EDGAR